カテゴリー： GlobalInfoResearch, 世界, 部品/材料

眼科用医薬品の世界市場2022：ジェル、点眼液、カプセル・錠剤、点眼薬、軟膏

◆英語タイトル：Global Drugs for Ophthalmology Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22DC0500 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2023年1月 ◆ページ数：105 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：化学＆材料

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

世界の眼科用医薬品市場レポートは、グローバル市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
Global Info Research社の最新のリサーチによると、世界の眼科用医薬品の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

眼科用医薬品市場はタイプとアプリケーションによって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・ジェル、点眼液、カプセル・錠剤、点眼薬、軟膏

アプリケーション別セグメントは次のように区分されます。
・病院、薬局

世界の眼科用医薬品市場の主要な市場プレーヤーは以下のとおりです。
・Allergan、Aerie Pharmaceuticals、Pfizer、Valeant、Bayer、Genentech、Novartis、Regeneron、Takeda、Santen Pharmaceutical

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・欧州（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南米（ブラジル、アルゼンチン、コロンビア）
・中東/アフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査資料の内容は計15章あります。
・第1章では、眼科用医薬品製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な眼科用医薬品メーカーの企業概要、2019年～2022年までの眼科用医薬品の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な眼科用医薬品メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別眼科用医薬品の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの眼科用医薬品の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での眼科用医薬品市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および眼科用医薬品の産業チェーンを掲載しています。
・第13、14、15章では、眼科用医薬品の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
– 眼科用医薬品の概要
– 種類別分析（2017年vs2021年vs2028年）：ジェル、点眼液、カプセル・錠剤、点眼薬、軟膏
– 用途別分析（2017年vs2021年vs2028年）：病院、薬局
– 世界の眼科用医薬品市場規模・予測
– 世界の眼科用医薬品生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Allergan、Aerie Pharmaceuticals、Pfizer、Valeant、Bayer、Genentech、Novartis、Regeneron、Takeda、Santen Pharmaceutical
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ジェル、点眼液、カプセル・錠剤、点眼薬、軟膏
・用途別分析2017年-2028年：病院、薬局
・眼科用医薬品の北米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・眼科用医薬品のヨーロッパ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・眼科用医薬品のアジア市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・眼科用医薬品の南米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・眼科用医薬品の中東・アフリカ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

❖ レポートの目次 ❖

1 Market Overview
1.1 Drugs for Ophthalmology Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Drugs for Ophthalmology Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Gels
1.2.3 Eye Solutions
1.2.4 Capsules & Tablets
1.2.5 Eye Drops
1.2.6 Ointments
1.3 Market Analysis by Application
1.3.1 Overview: Global Drugs for Ophthalmology Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Global Drugs for Ophthalmology Market Size & Forecast
1.4.1 Global Drugs for Ophthalmology Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Drugs for Ophthalmology Sales in Volume (2017-2028)
1.4.3 Global Drugs for Ophthalmology Price (2017-2028)
1.5 Global Drugs for Ophthalmology Production Capacity Analysis
1.5.1 Global Drugs for Ophthalmology Total Production Capacity (2017-2028)
1.5.2 Global Drugs for Ophthalmology Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Drugs for Ophthalmology Market Drivers
1.6.2 Drugs for Ophthalmology Market Restraints
1.6.3 Drugs for Ophthalmology Trends Analysis
2 Manufacturers Profiles
2.1 Allergan
2.1.1 Allergan Details
2.1.2 Allergan Major Business
2.1.3 Allergan Drugs for Ophthalmology Product and Services
2.1.4 Allergan Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Aerie Pharmaceuticals
2.2.1 Aerie Pharmaceuticals Details
2.2.2 Aerie Pharmaceuticals Major Business
2.2.3 Aerie Pharmaceuticals Drugs for Ophthalmology Product and Services
2.2.4 Aerie Pharmaceuticals Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Drugs for Ophthalmology Product and Services
2.3.4 Pfizer Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Valeant
2.4.1 Valeant Details
2.4.2 Valeant Major Business
2.4.3 Valeant Drugs for Ophthalmology Product and Services
2.4.4 Valeant Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business
2.5.3 Bayer Drugs for Ophthalmology Product and Services
2.5.4 Bayer Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Genentech
2.6.1 Genentech Details
2.6.2 Genentech Major Business
2.6.3 Genentech Drugs for Ophthalmology Product and Services
2.6.4 Genentech Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Drugs for Ophthalmology Product and Services
2.7.4 Novartis Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Regeneron
2.8.1 Regeneron Details
2.8.2 Regeneron Major Business
2.8.3 Regeneron Drugs for Ophthalmology Product and Services
2.8.4 Regeneron Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Takeda
2.9.1 Takeda Details
2.9.2 Takeda Major Business
2.9.3 Takeda Drugs for Ophthalmology Product and Services
2.9.4 Takeda Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Santen Pharmaceutical
2.10.1 Santen Pharmaceutical Details
2.10.2 Santen Pharmaceutical Major Business
2.10.3 Santen Pharmaceutical Drugs for Ophthalmology Product and Services
2.10.4 Santen Pharmaceutical Drugs for Ophthalmology Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Drugs for Ophthalmology Breakdown Data by Manufacturer
3.1 Global Drugs for Ophthalmology Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Drugs for Ophthalmology Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Drugs for Ophthalmology
3.4 Market Concentration Rate
3.4.1 Top 3 Drugs for Ophthalmology Manufacturer Market Share in 2021
3.4.2 Top 6 Drugs for Ophthalmology Manufacturer Market Share in 2021
3.5 Global Drugs for Ophthalmology Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Drugs for Ophthalmology Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Drugs for Ophthalmology Market Size by Region
4.1.1 Global Drugs for Ophthalmology Sales in Volume by Region (2017-2028)
4.1.2 Global Drugs for Ophthalmology Revenue by Region (2017-2028)
4.2 North America Drugs for Ophthalmology Revenue (2017-2028)
4.3 Europe Drugs for Ophthalmology Revenue (2017-2028)
4.4 Asia-Pacific Drugs for Ophthalmology Revenue (2017-2028)
4.5 South America Drugs for Ophthalmology Revenue (2017-2028)
4.6 Middle East and Africa Drugs for Ophthalmology Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Drugs for Ophthalmology Sales in Volume by Type (2017-2028)
5.2 Global Drugs for Ophthalmology Revenue by Type (2017-2028)
5.3 Global Drugs for Ophthalmology Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Drugs for Ophthalmology Sales in Volume by Application (2017-2028)
6.2 Global Drugs for Ophthalmology Revenue by Application (2017-2028)
6.3 Global Drugs for Ophthalmology Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Drugs for Ophthalmology Sales by Type (2017-2028)
7.2 North America Drugs for Ophthalmology Sales by Application (2017-2028)
7.3 North America Drugs for Ophthalmology Market Size by Country
7.3.1 North America Drugs for Ophthalmology Sales in Volume by Country (2017-2028)
7.3.2 North America Drugs for Ophthalmology Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Drugs for Ophthalmology Sales by Type (2017-2028)
8.2 Europe Drugs for Ophthalmology Sales by Application (2017-2028)
8.3 Europe Drugs for Ophthalmology Market Size by Country
8.3.1 Europe Drugs for Ophthalmology Sales in Volume by Country (2017-2028)
8.3.2 Europe Drugs for Ophthalmology Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Drugs for Ophthalmology Sales by Type (2017-2028)
9.2 Asia-Pacific Drugs for Ophthalmology Sales by Application (2017-2028)
9.3 Asia-Pacific Drugs for Ophthalmology Market Size by Region
9.3.1 Asia-Pacific Drugs for Ophthalmology Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Drugs for Ophthalmology Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Drugs for Ophthalmology Sales by Type (2017-2028)
10.2 South America Drugs for Ophthalmology Sales by Application (2017-2028)
10.3 South America Drugs for Ophthalmology Market Size by Country
10.3.1 South America Drugs for Ophthalmology Sales in Volume by Country (2017-2028)
10.3.2 South America Drugs for Ophthalmology Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Drugs for Ophthalmology Sales by Type (2017-2028)
11.2 Middle East & Africa Drugs for Ophthalmology Sales by Application (2017-2028)
11.3 Middle East & Africa Drugs for Ophthalmology Market Size by Country
11.3.1 Middle East & Africa Drugs for Ophthalmology Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Drugs for Ophthalmology Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Drugs for Ophthalmology and Key Manufacturers
12.2 Manufacturing Costs Percentage of Drugs for Ophthalmology
12.3 Drugs for Ophthalmology Production Process
12.4 Drugs for Ophthalmology Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Drugs for Ophthalmology Typical Distributors
13.3 Drugs for Ophthalmology Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Drugs for Ophthalmology Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Drugs for Ophthalmology Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Allergan Basic Information, Manufacturing Base and Competitors
Table 4. Allergan Major Business
Table 5. Allergan Drugs for Ophthalmology Product and Services
Table 6. Allergan Drugs for Ophthalmology Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Aerie Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Aerie Pharmaceuticals Major Business
Table 9. Aerie Pharmaceuticals Drugs for Ophthalmology Product and Services
Table 10. Aerie Pharmaceuticals Drugs for Ophthalmology Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Drugs for Ophthalmology Product and Services
Table 14. Pfizer Drugs for Ophthalmology Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Valeant Basic Information, Manufacturing Base and Competitors
Table 16. Valeant Major Business
Table 17. Valeant Drugs for Ophthalmology Product and Services
Table 18. Valeant Drugs for Ophthalmology Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Bayer Basic Information, Manufacturing Base and Competitors
Table 20. Bayer Major Business
Table 21. Bayer Drugs for Ophthalmology Product and Services
Table 22. Bayer Drugs for Ophthalmology Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Genentech Basic Information, Manufacturing Base and Competitors
Table 24. Genentech Major Business
Table 25. Genentech Drugs for Ophthalmology Product and Services
Table 26. Genentech Drugs for Ophthalmology Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Novartis Basic Information, Manufacturing Base and Competitors
Table 28. Novartis Major Business
Table 29. Novartis Drugs for Ophthalmology Product and Services
Table 30. Novartis Drugs for Ophthalmology Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Regeneron Basic Information, Manufacturing Base and Competitors
Table 32. Regeneron Major Business
Table 33. Regeneron Drugs for Ophthalmology Product and Services
Table 34. Regeneron Drugs for Ophthalmology Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Takeda Basic Information, Manufacturing Base and Competitors
Table 36. Takeda Major Business
Table 37. Takeda Drugs for Ophthalmology Product and Services
Table 38. Takeda Drugs for Ophthalmology Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Santen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 40. Santen Pharmaceutical Major Business
Table 41. Santen Pharmaceutical Drugs for Ophthalmology Product and Services
Table 42. Santen Pharmaceutical Drugs for Ophthalmology Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Drugs for Ophthalmology Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Drugs for Ophthalmology Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Drugs for Ophthalmology, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Drugs for Ophthalmology Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Drugs for Ophthalmology Production Site of Key Manufacturer
Table 48. Drugs for Ophthalmology New Entrant and Capacity Expansion Plans
Table 49. Drugs for Ophthalmology Mergers & Acquisitions in the Past Five Years
Table 50. Global Drugs for Ophthalmology Sales by Region (2017-2022) & (K Units)
Table 51. Global Drugs for Ophthalmology Sales by Region (2023-2028) & (K Units)
Table 52. Global Drugs for Ophthalmology Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Drugs for Ophthalmology Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Drugs for Ophthalmology Sales by Type (2017-2022) & (K Units)
Table 55. Global Drugs for Ophthalmology Sales by Type (2023-2028) & (K Units)
Table 56. Global Drugs for Ophthalmology Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Drugs for Ophthalmology Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Drugs for Ophthalmology Price by Type (2017-2022) & (USD/Unit)
Table 59. Global Drugs for Ophthalmology Price by Type (2023-2028) & (USD/Unit)
Table 60. Global Drugs for Ophthalmology Sales by Application (2017-2022) & (K Units)
Table 61. Global Drugs for Ophthalmology Sales by Application (2023-2028) & (K Units)
Table 62. Global Drugs for Ophthalmology Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Drugs for Ophthalmology Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Drugs for Ophthalmology Price by Application (2017-2022) & (USD/Unit)
Table 65. Global Drugs for Ophthalmology Price by Application (2023-2028) & (USD/Unit)
Table 66. North America Drugs for Ophthalmology Sales by Country (2017-2022) & (K Units)
Table 67. North America Drugs for Ophthalmology Sales by Country (2023-2028) & (K Units)
Table 68. North America Drugs for Ophthalmology Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Drugs for Ophthalmology Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Drugs for Ophthalmology Sales by Type (2017-2022) & (K Units)
Table 71. North America Drugs for Ophthalmology Sales by Type (2023-2028) & (K Units)
Table 72. North America Drugs for Ophthalmology Sales by Application (2017-2022) & (K Units)
Table 73. North America Drugs for Ophthalmology Sales by Application (2023-2028) & (K Units)
Table 74. Europe Drugs for Ophthalmology Sales by Country (2017-2022) & (K Units)
Table 75. Europe Drugs for Ophthalmology Sales by Country (2023-2028) & (K Units)
Table 76. Europe Drugs for Ophthalmology Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Drugs for Ophthalmology Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Drugs for Ophthalmology Sales by Type (2017-2022) & (K Units)
Table 79. Europe Drugs for Ophthalmology Sales by Type (2023-2028) & (K Units)
Table 80. Europe Drugs for Ophthalmology Sales by Application (2017-2022) & (K Units)
Table 81. Europe Drugs for Ophthalmology Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Drugs for Ophthalmology Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Drugs for Ophthalmology Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Drugs for Ophthalmology Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Drugs for Ophthalmology Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Drugs for Ophthalmology Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Drugs for Ophthalmology Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Drugs for Ophthalmology Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Drugs for Ophthalmology Sales by Application (2023-2028) & (K Units)
Table 90. South America Drugs for Ophthalmology Sales by Country (2017-2022) & (K Units)
Table 91. South America Drugs for Ophthalmology Sales by Country (2023-2028) & (K Units)
Table 92. South America Drugs for Ophthalmology Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Drugs for Ophthalmology Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Drugs for Ophthalmology Sales by Type (2017-2022) & (K Units)
Table 95. South America Drugs for Ophthalmology Sales by Type (2023-2028) & (K Units)
Table 96. South America Drugs for Ophthalmology Sales by Application (2017-2022) & (K Units)
Table 97. South America Drugs for Ophthalmology Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Drugs for Ophthalmology Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Drugs for Ophthalmology Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Drugs for Ophthalmology Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Drugs for Ophthalmology Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Drugs for Ophthalmology Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Drugs for Ophthalmology Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Drugs for Ophthalmology Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Drugs for Ophthalmology Sales by Application (2023-2028) & (K Units)
Table 106. Drugs for Ophthalmology Raw Material
Table 107. Key Manufacturers of Drugs for Ophthalmology Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Drugs for Ophthalmology Typical Distributors
Table 111. Drugs for Ophthalmology Typical Customers
List of Figures
Figure 1. Drugs for Ophthalmology Picture
Figure 2. Global Drugs for Ophthalmology Revenue Market Share by Type in 2021
Figure 3. Gels
Figure 4. Eye Solutions
Figure 5. Capsules & Tablets
Figure 6. Eye Drops
Figure 7. Ointments
Figure 8. Global Drugs for Ophthalmology Revenue Market Share by Application in 2021
Figure 9. Hospital
Figure 10. Retail Pharmacy
Figure 11. Global Drugs for Ophthalmology Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Drugs for Ophthalmology Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Drugs for Ophthalmology Sales (2017-2028) & (K Units)
Figure 14. Global Drugs for Ophthalmology Price (2017-2028) & (USD/Unit)
Figure 15. Global Drugs for Ophthalmology Production Capacity (2017-2028) & (K Units)
Figure 16. Global Drugs for Ophthalmology Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Drugs for Ophthalmology Market Drivers
Figure 18. Drugs for Ophthalmology Market Restraints
Figure 19. Drugs for Ophthalmology Market Trends
Figure 20. Global Drugs for Ophthalmology Sales Market Share by Manufacturer in 2021
Figure 21. Global Drugs for Ophthalmology Revenue Market Share by Manufacturer in 2021
Figure 22. Drugs for Ophthalmology Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Drugs for Ophthalmology Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Drugs for Ophthalmology Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Drugs for Ophthalmology Sales Market Share by Region (2017-2028)
Figure 26. Global Drugs for Ophthalmology Revenue Market Share by Region (2017-2028)
Figure 27. North America Drugs for Ophthalmology Revenue (2017-2028) & (USD Million)
Figure 28. Europe Drugs for Ophthalmology Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Drugs for Ophthalmology Revenue (2017-2028) & (USD Million)
Figure 30. South America Drugs for Ophthalmology Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Drugs for Ophthalmology Revenue (2017-2028) & (USD Million)
Figure 32. Global Drugs for Ophthalmology Sales Market Share by Type (2017-2028)
Figure 33. Global Drugs for Ophthalmology Revenue Market Share by Type (2017-2028)
Figure 34. Global Drugs for Ophthalmology Price by Type (2017-2028) & (USD/Unit)
Figure 35. Global Drugs for Ophthalmology Sales Market Share by Application (2017-2028)
Figure 36. Global Drugs for Ophthalmology Revenue Market Share by Application (2017-2028)
Figure 37. Global Drugs for Ophthalmology Price by Application (2017-2028) & (USD/Unit)
Figure 38. North America Drugs for Ophthalmology Sales Market Share by Type (2017-2028)
Figure 39. North America Drugs for Ophthalmology Sales Market Share by Application (2017-2028)
Figure 40. North America Drugs for Ophthalmology Sales Market Share by Country (2017-2028)
Figure 41. North America Drugs for Ophthalmology Revenue Market Share by Country (2017-2028)
Figure 42. United States Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Drugs for Ophthalmology Sales Market Share by Type (2017-2028)
Figure 46. Europe Drugs for Ophthalmology Sales Market Share by Application (2017-2028)
Figure 47. Europe Drugs for Ophthalmology Sales Market Share by Country (2017-2028)
Figure 48. Europe Drugs for Ophthalmology Revenue Market Share by Country (2017-2028)
Figure 49. Germany Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Drugs for Ophthalmology Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Drugs for Ophthalmology Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Drugs for Ophthalmology Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Drugs for Ophthalmology Revenue Market Share by Region (2017-2028)
Figure 58. China Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Drugs for Ophthalmology Sales Market Share by Type (2017-2028)
Figure 65. South America Drugs for Ophthalmology Sales Market Share by Application (2017-2028)
Figure 66. South America Drugs for Ophthalmology Sales Market Share by Country (2017-2028)
Figure 67. South America Drugs for Ophthalmology Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Drugs for Ophthalmology Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Drugs for Ophthalmology Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Drugs for Ophthalmology Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Drugs for Ophthalmology Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Drugs for Ophthalmology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Drugs for Ophthalmology in 2021
Figure 79. Manufacturing Process Analysis of Drugs for Ophthalmology
Figure 80. Drugs for Ophthalmology Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 眼科用医薬品の世界市場2022：ジェル、点眼液、カプセル・錠剤、点眼薬、軟膏(Global Drugs for Ophthalmology Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

眼科用医薬品の世界市場2022：ジェル、点眼液、カプセル・錠剤、点眼薬、軟膏

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp